1 Study Coverage
1.1 Inhalers Product Introduction
1.2 Global Inhalers Outlook 2017 VS 2022 VS 2028
1.2.1 Global Inhalers Sales in US$ Million for the Year 2017-2028
1.2.2 Global Inhalers Sales in Volume for the Year 2017-2028
1.3 United States Inhalers Outlook 2017 VS 2022 VS 2028
1.3.1 United States Inhalers Sales in US$ Million for the Year 2017-2028
1.3.2 United States Inhalers Sales in Volume for the Year 2017-2028
1.4 Inhalers Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Inhalers in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Inhalers Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Inhalers Market Dynamics
1.5.1 Inhalers Industry Trends
1.5.2 Inhalers Market Drivers
1.5.3 Inhalers Market Challenges
1.5.4 Inhalers Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Inhalers Market Segment by Type
2.1.1 Metered Dose Inhalers
2.1.2 Dry Powder Inhalers
2.1.3 Nasal Inhalers
2.1.4 Other
2.2 Global Inhalers Market Size by Type
2.2.1 Global Inhalers Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Inhalers Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Inhalers Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Inhalers Market Size by Type
2.3.1 United States Inhalers Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Inhalers Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Inhalers Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Inhalers Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Respiratory Care Centers
3.1.4 Others
3.2 Global Inhalers Market Size by Application
3.2.1 Global Inhalers Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Inhalers Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Inhalers Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Inhalers Market Size by Application
3.3.1 United States Inhalers Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Inhalers Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Inhalers Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Inhalers Competitor Landscape by Company
4.1 Global Inhalers Market Size by Company
4.1.1 Top Global Inhalers Manufacturers Ranked by Revenue (2021)
4.1.2 Global Inhalers Revenue by Manufacturer (2017-2022)
4.1.3 Global Inhalers Sales by Manufacturer (2017-2022)
4.1.4 Global Inhalers Price by Manufacturer (2017-2022)
4.2 Global Inhalers Concentration Ratio (CR)
4.2.1 Inhalers Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Inhalers in 2021
4.2.3 Global Inhalers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Inhalers Manufacturing Base Distribution, Product Type
4.3.1 Global Inhalers Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Inhalers Product Type
4.3.3 Date of International Manufacturers Enter into Inhalers Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Inhalers Market Size by Company
4.5.1 Top Inhalers Players in United States, Ranked by Revenue (2021)
4.5.2 United States Inhalers Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Inhalers Sales by Players (2020, 2021 & 2022)
5 Global Inhalers Market Size by Region
5.1 Global Inhalers Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Inhalers Market Size in Volume by Region (2017-2028)
5.2.1 Global Inhalers Sales in Volume by Region: 2017-2022
5.2.2 Global Inhalers Sales in Volume Forecast by Region (2023-2028)
5.3 Global Inhalers Market Size in Value by Region (2017-2028)
5.3.1 Global Inhalers Sales in Value by Region: 2017-2022
5.3.2 Global Inhalers Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Inhalers Market Size YoY Growth 2017-2028
6.1.2 North America Inhalers Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Inhalers Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Inhalers Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Inhalers Market Size YoY Growth 2017-2028
6.3.2 Europe Inhalers Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Inhalers Market Size YoY Growth 2017-2028
6.4.2 Latin America Inhalers Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Inhalers Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Inhalers Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporation Information
7.1.2 GlaxoSmithKline Description and Business Overview
7.1.3 GlaxoSmithKline Inhalers Sales, Revenue and Gross Margin (2017-2022)
7.1.4 GlaxoSmithKline Inhalers Products Offered
7.1.5 GlaxoSmithKline Recent Development
7.2 Merck
7.2.1 Merck Corporation Information
7.2.2 Merck Description and Business Overview
7.2.3 Merck Inhalers Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Merck Inhalers Products Offered
7.2.5 Merck Recent Development
7.3 AstraZeneca
7.3.1 AstraZeneca Corporation Information
7.3.2 AstraZeneca Description and Business Overview
7.3.3 AstraZeneca Inhalers Sales, Revenue and Gross Margin (2017-2022)
7.3.4 AstraZeneca Inhalers Products Offered
7.3.5 AstraZeneca Recent Development
7.4 Boehringer-Ingelheim
7.4.1 Boehringer-Ingelheim Corporation Information
7.4.2 Boehringer-Ingelheim Description and Business Overview
7.4.3 Boehringer-Ingelheim Inhalers Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Boehringer-Ingelheim Inhalers Products Offered
7.4.5 Boehringer-Ingelheim Recent Development
7.5 3M
7.5.1 3M Corporation Information
7.5.2 3M Description and Business Overview
7.5.3 3M Inhalers Sales, Revenue and Gross Margin (2017-2022)
7.5.4 3M Inhalers Products Offered
7.5.5 3M Recent Development
7.6 Teva
7.6.1 Teva Corporation Information
7.6.2 Teva Description and Business Overview
7.6.3 Teva Inhalers Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Teva Inhalers Products Offered
7.6.5 Teva Recent Development
7.7 Sunovion Pharmaceuticals
7.7.1 Sunovion Pharmaceuticals Corporation Information
7.7.2 Sunovion Pharmaceuticals Description and Business Overview
7.7.3 Sunovion Pharmaceuticals Inhalers Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Sunovion Pharmaceuticals Inhalers Products Offered
7.7.5 Sunovion Pharmaceuticals Recent Development
7.8 Aristopharma
7.8.1 Aristopharma Corporation Information
7.8.2 Aristopharma Description and Business Overview
7.8.3 Aristopharma Inhalers Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Aristopharma Inhalers Products Offered
7.8.5 Aristopharma Recent Development
7.9 Novartis
7.9.1 Novartis Corporation Information
7.9.2 Novartis Description and Business Overview
7.9.3 Novartis Inhalers Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Novartis Inhalers Products Offered
7.9.5 Novartis Recent Development
7.10 Vectura Group
7.10.1 Vectura Group Corporation Information
7.10.2 Vectura Group Description and Business Overview
7.10.3 Vectura Group Inhalers Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Vectura Group Inhalers Products Offered
7.10.5 Vectura Group Recent Development
7.11 MannKind
7.11.1 MannKind Corporation Information
7.11.2 MannKind Description and Business Overview
7.11.3 MannKind Inhalers Sales, Revenue and Gross Margin (2017-2022)
7.11.4 MannKind Inhalers Products Offered
7.11.5 MannKind Recent Development
7.12 Respirices
7.12.1 Respirices Corporation Information
7.12.2 Respirices Description and Business Overview
7.12.3 Respirices Inhalers Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Respirices Products Offered
7.12.5 Respirices Recent Development
7.13 Orion Pharm
7.13.1 Orion Pharm Corporation Information
7.13.2 Orion Pharm Description and Business Overview
7.13.3 Orion Pharm Inhalers Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Orion Pharm Products Offered
7.13.5 Orion Pharm Recent Development
7.14 Hovione
7.14.1 Hovione Corporation Information
7.14.2 Hovione Description and Business Overview
7.14.3 Hovione Inhalers Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Hovione Products Offered
7.14.5 Hovione Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Inhalers Industry Chain Analysis
8.2 Inhalers Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Inhalers Distributors
8.3 Inhalers Production Mode & Process
8.4 Inhalers Sales and Marketing
8.4.1 Inhalers Sales Channels
8.4.2 Inhalers Distributors
8.5 Inhalers Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Inhalers CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Inhalers Market Trends
Table 3. Inhalers Market Drivers
Table 4. Inhalers Market Challenges
Table 5. Inhalers Market Restraints
Table 6. Global Inhalers Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Inhalers Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Inhalers Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Inhalers Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Inhalers Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Inhalers Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Inhalers Revenue Share by Manufacturer, 2017-2022
Table 13. Global Inhalers Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Inhalers Sales Share by Manufacturer, 2017-2022
Table 15. Global Inhalers Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Inhalers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Inhalers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalers as of 2021)
Table 18. Top Players of Inhalers in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Inhalers Product Type
Table 20. Date of International Manufacturers Enter into Inhalers Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Inhalers Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Inhalers Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Inhalers Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Inhalers Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Inhalers Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Inhalers Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Inhalers Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Inhalers Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Inhalers Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Inhalers Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Inhalers Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Inhalers Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Inhalers Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Inhalers Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Inhalers Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Inhalers Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Inhalers Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Inhalers Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Inhalers Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Inhalers Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. GlaxoSmithKline Corporation Information
Table 43. GlaxoSmithKline Description and Business Overview
Table 44. GlaxoSmithKline Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. GlaxoSmithKline Inhalers Product
Table 46. GlaxoSmithKline Recent Development
Table 47. Merck Corporation Information
Table 48. Merck Description and Business Overview
Table 49. Merck Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Merck Product
Table 51. Merck Recent Development
Table 52. AstraZeneca Corporation Information
Table 53. AstraZeneca Description and Business Overview
Table 54. AstraZeneca Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. AstraZeneca Product
Table 56. AstraZeneca Recent Development
Table 57. Boehringer-Ingelheim Corporation Information
Table 58. Boehringer-Ingelheim Description and Business Overview
Table 59. Boehringer-Ingelheim Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Boehringer-Ingelheim Product
Table 61. Boehringer-Ingelheim Recent Development
Table 62. 3M Corporation Information
Table 63. 3M Description and Business Overview
Table 64. 3M Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. 3M Product
Table 66. 3M Recent Development
Table 67. Teva Corporation Information
Table 68. Teva Description and Business Overview
Table 69. Teva Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Teva Product
Table 71. Teva Recent Development
Table 72. Sunovion Pharmaceuticals Corporation Information
Table 73. Sunovion Pharmaceuticals Description and Business Overview
Table 74. Sunovion Pharmaceuticals Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Sunovion Pharmaceuticals Product
Table 76. Sunovion Pharmaceuticals Recent Development
Table 77. Aristopharma Corporation Information
Table 78. Aristopharma Description and Business Overview
Table 79. Aristopharma Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Aristopharma Product
Table 81. Aristopharma Recent Development
Table 82. Novartis Corporation Information
Table 83. Novartis Description and Business Overview
Table 84. Novartis Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Novartis Product
Table 86. Novartis Recent Development
Table 87. Vectura Group Corporation Information
Table 88. Vectura Group Description and Business Overview
Table 89. Vectura Group Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Vectura Group Product
Table 91. Vectura Group Recent Development
Table 92. MannKind Corporation Information
Table 93. MannKind Description and Business Overview
Table 94. MannKind Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. MannKind Product
Table 96. MannKind Recent Development
Table 97. Respirices Corporation Information
Table 98. Respirices Description and Business Overview
Table 99. Respirices Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Respirices Product
Table 101. Respirices Recent Development
Table 102. Orion Pharm Corporation Information
Table 103. Orion Pharm Description and Business Overview
Table 104. Orion Pharm Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 105. Orion Pharm Product
Table 106. Orion Pharm Recent Development
Table 107. Hovione Corporation Information
Table 108. Hovione Description and Business Overview
Table 109. Hovione Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Hovione Product
Table 111. Hovione Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Inhalers Customers List
Table 115. Inhalers Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Inhalers Product Picture
Figure 2. Global Inhalers Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Inhalers Market Size 2017-2028 (US$ Million)
Figure 4. Global Inhalers Sales 2017-2028 (K Units)
Figure 5. United States Inhalers Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Inhalers Market Size 2017-2028 (US$ Million)
Figure 7. United States Inhalers Sales 2017-2028 (K Units)
Figure 8. United States Inhalers Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Inhalers Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Inhalers Report Years Considered
Figure 11. Product Picture of Metered Dose Inhalers
Figure 12. Product Picture of Dry Powder Inhalers
Figure 13. Product Picture of Nasal Inhalers
Figure 14. Product Picture of Other
Figure 15. Global Inhalers Market Share by Type in 2022 & 2028
Figure 16. Global Inhalers Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Inhalers Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Inhalers Sales by Type (2017-2028) & (K Units)
Figure 19. Global Inhalers Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Inhalers Price by Type (2017-2028) & (USD/Unit)
Figure 21. United States Inhalers Market Share by Type in 2022 & 2028
Figure 22. United States Inhalers Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Inhalers Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Inhalers Sales by Type (2017-2028) & (K Units)
Figure 25. United States Inhalers Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Inhalers Price by Type (2017-2028) & (USD/Unit)
Figure 27. Product Picture of Hospital
Figure 28. Product Picture of Clinic
Figure 29. Product Picture of Respiratory Care Centers
Figure 30. Product Picture of Others
Figure 31. Global Inhalers Market Share by Application in 2022 & 2028
Figure 32. Global Inhalers Sales in Value by Application (2017-2028) & (US$ Million)
Figure 33. Global Inhalers Sales Market Share in Value by Application (2017-2028)
Figure 34. Global Inhalers Sales by Application (2017-2028) & (K Units)
Figure 35. Global Inhalers Sales Market Share in Volume by Application (2017-2028)
Figure 36. Global Inhalers Price by Application (2017-2028) & (USD/Unit)
Figure 37. United States Inhalers Market Share by Application in 2022 & 2028
Figure 38. United States Inhalers Sales in Value by Application (2017-2028) & (US$ Million)
Figure 39. United States Inhalers Sales Market Share in Value by Application (2017-2028)
Figure 40. United States Inhalers Sales by Application (2017-2028) & (K Units)
Figure 41. United States Inhalers Sales Market Share in Volume by Application (2017-2028)
Figure 42. United States Inhalers Price by Application (2017-2028) & (USD/Unit)
Figure 43. North America Inhalers Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 44. North America Inhalers Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. U.S. Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Canada Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Europe Inhalers Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 48. Europe Inhalers Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 49. Germany Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. France Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. U.K. Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Italy Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Russia Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Asia-Pacific Inhalers Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 55. Asia-Pacific Inhalers Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 56. China Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Japan Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. South Korea Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. India Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Australia Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Taiwan Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Indonesia Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Thailand Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Malaysia Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Philippines Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Latin America Inhalers Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 67. Latin America Inhalers Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 68. Mexico Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Brazil Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Argentina Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Middle East & Africa Inhalers Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 72. Middle East & Africa Inhalers Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 73. Turkey Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Saudi Arabia Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. UAE Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Inhalers Value Chain
Figure 77. Inhalers Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline Merck AstraZeneca Boehringer-Ingelheim 3M Teva Sunovion Pharmaceuticals Aristopharma Novartis Vectura Group MannKind Respirices Orion Pharm Hovione